TP53 and B-cell chronic lymphocytic leukemia: In addition to the mutational analysis, we also focused on the co‐occurrence of del(11q)/ATM mutations and del(17p)/TP53 mutations in CLL patients, according to the presence of monoallelic or biallelic alteration and the type of the genetic alteration: deletion or gene mutation.